Citations (114)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Alexander P. Davis, Steven C. Kao, Stephen J. Clarke, Michael Boyer & Nick Pavlakis. (2021) Emerging biological therapies for the treatment of malignant pleural mesothelioma. Expert Opinion on Emerging Drugs 26:2, pages 179-192.
Read now
Read now
A. Michael Ierardi & Gary M. Marsh. (2020) Absence of mesothelioma risk maintained in an expanded international cohort of cosmetic talc miners and millers. Inhalation Toxicology 32:6, pages 257-264.
Read now
Read now
Laura M Enomoto, Perry Shen, Edward A Levine & Konstantinos I Votanopoulos. (2019) Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations. Cancer Management and Research 11, pages 4231-4241.
Read now
Read now
Gary M. Marsh, A. Michael Ierardi, Stacey M. Benson & Brent L. Finley. (2019) Occupational exposures to cosmetic talc and risk of mesothelioma: an updated pooled cohort and statistical power analysis with consideration of latency period. Inhalation Toxicology 31:6, pages 213-223.
Read now
Read now
Richard A. Lemen. (2016) Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States. Journal of Toxicology and Environmental Health, Part B 19:5-6, pages 250-265.
Read now
Read now
Francine Baumann & Michele Carbone. (2016) Environmental risk of mesothelioma in the United States: An emerging concern—epidemiological issues. Journal of Toxicology and Environmental Health, Part B 19:5-6, pages 231-249.
Read now
Read now
Laurel M. Schunselaar, Josine M.M.F. Quispel-Janssen, Jacques J. C. Neefjes & Paul Baas. (2016) A catalogue of treatment and technologies for malignant pleural mesothelioma. Expert Review of Anticancer Therapy 16:4, pages 455-463.
Read now
Read now
Articles from other publishers (107)
Jefree J Schulte & Aliya N Husain. (2023) Updates on grading mesothelioma. Histopathology.
Crossref
Crossref
Xaver Baur, Arthur L. Frank, Corrado Magnani, L. Christine Oliver & Colin L. Soskolne. (2023) Malignant mesothelioma in females: the institutional failure by WHO and IARC to protect public health. The Journal of Scientific Practice and Integrity.
Crossref
Crossref
Steven Richard Smith. (2023) An updated review of diffuse mesothelioma of the pleura – A sentinel health event of potential elongate mineral particle pathogenicity. Environmental Research 230, pages 115608.
Crossref
Crossref
Owen D. Mitchell, Katie Gilliam, Daniela del Gaudio, Kelsey E. McNeely, Shaili Smith, Maria Acevedo, Meghana Gaduraju, Rachel Hodge, Aubrianna S. S. Ramsland, Jeremy Segal, Soma Das, Feighanne Hathaway, Darren S. Bryan, Sanjukta Tawde, Shelly Galasinski, Peng Wang, Melissa Y. Tjota, Aliya N. Husain, Samuel G. ArmatoIIIIII, Jessica Donington, Mark K. Ferguson, Kiran Turaga, Jane E. Churpek, Hedy L. Kindler & Michael W. Drazer. (2023) Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma. JAMA Network Open 6:8, pages e2327351.
Crossref
Crossref
Chad D. Strange, Edith M. Marom, Jitesh Ahuja, Girish S. Shroff, Gregory W. Gladish, Brett W. Carter & Mylene T. Truong. (2023) Imaging of Malignant Pleural, Pericardial, and Peritoneal Mesothelioma. Advances in Anatomic Pathology 30:4, pages 280-291.
Crossref
Crossref
Junjie Huang, Sze Chai Chan, Wing Sze Pang, Shui Hang Chow, Veeleah Lok, Lin Zhang, Xu Lin, Don Eliseo Lucero-PrisnoIIIIII, Wanghong Xu, Zhi-Jie Zheng, Edmar Elcarte, Mellissa Withers & Martin C.S. Wong. (2023) Global Incidence, Risk Factors, and Temporal Trends of Mesothelioma: A Population-Based Study. Journal of Thoracic Oncology 18:6, pages 792-802.
Crossref
Crossref
R. Taylor Ripley, Hudson M. Holmes, Richard S. Whitlock, Shawn S. Groth, Cristian G. Medina, Eugene A. Choi, Bryan M. Burt & Paul H. Sugarbaker. (2023) Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy. The Journal of Thoracic and Cardiovascular Surgery 165:5, pages 1722-1730.
Crossref
Crossref
Hüsnü BAYKAL & Filiz ÇİMEN. (2023) A biomarker predicting unfavorable prognosis in malignant pleural mesothelioma: systemic immune–inflammation index. Journal of Health Sciences and Medicine 6:2, pages 389-393.
Crossref
Crossref
Sharyn I. Katz, Christopher M. Straus, Leonid Roshkovan, Kevin G. Blyth, Thomas Frauenfelder, Ritu R. Gill, Ferry Lalezari, Jeremy Erasmus, Anna K. Nowak, Victor H. Gerbaudo, Roslyn J. Francis & Samuel G. ArmatoIIIIII. (2023) Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group. Journal of Thoracic Oncology 18:3, pages 278-298.
Crossref
Crossref
Melina E. Marmarelis, Xiao Wang, Leonid Roshkovan, Connor B. Grady, John T. Miura, Michelle S. Ginsberg, Christine A. Ciunci, Jacklynn Egger, Suzanne Walker, Andrea Cercek, Michael B. Foote, Leslie A. Litzky, Garrett Nash, Andrew R. Haas, Giorgos C. Karakousis, Keith A. Cengel, Sharyn I. Katz, Marjorie G. Zauderer, Corey J. Langer & Michael Offin. (2023) Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma. JAMA Network Open 6:3, pages e232526.
Crossref
Crossref
Lucia Calthorpe, Fernanda Romero-Hernandez, Phoebe Miller, Patricia C. Conroy, Kenzo Hirose, Alex Kim, Kimberly Kirkwood, Eric Nakakura, Carlos Corvera, Ajay V. Maker, Adnan Alseidi & Mohamed Abdelgadir Adam. (2022) Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States. Cancers 15:1, pages 229.
Crossref
Crossref
Jianting Ma & Shengzhi Zhang. (2022) Prognostic factors of malignant peritoneal mesothelioma: a retrospective study of 52 female patients. World Journal of Surgical Oncology 20:1.
Crossref
Crossref
Angelo Rizzolo, Kenny Chia Ah-Lan, Tuyet Nhung Ton Nu & Thierry Alcindor. (2022) Response to Ipilimumab and Nivolumab in a Patient With Malignant Peritoneal Mesothelioma. Clinical Colorectal Cancer 21:4, pages 371-374.
Crossref
Crossref
Annie Liu, Diana Cardona & Dan Blazer. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
8
.
David B. Chapel, Jason L. Hornick, Julianne Barlow, Raphael Bueno & Lynette M. Sholl. (2022) Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma. Modern Pathology 35:10, pages 1383-1397.
Crossref
Crossref
Swaroop Kumar Pandey, Renen Machlof-Cohen, Manikandan Santhanam, Anna Shteinfer-Kuzmine & Varda Shoshan-Barmatz. (2022) Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks. Biomolecules 12:7, pages 895.
Crossref
Crossref
Alaa Alnefaie, Sarah Albogami, Yousif Asiri, Tanveer Ahmad, Saqer S. Alotaibi, Mohammad M. Al-Sanea & Hisham Althobaiti. (2022) Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Hidetaka Uramoto, Tomoya Takiguchi, Tomonobu Koizumi, Azusa Tanimoto, Ryuji Hayashi, Yozo Nakazawa, Ken-ichi Ito, Mitsutoshi Nakada, Yasuo Hirono, Yoshikazu Nishino & Seiji Yano. (2021) Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region. Journal of Cancer Research and Clinical Oncology 148:5, pages 1153-1158.
Crossref
Crossref
Bradley Carlson, Carla Harmath, Kiran Turaga, Hedy L. Kindler, Samuel G. ArmatoIIIIII & Christopher Straus. (2022) The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review. Abdominal Radiology 47:5, pages 1725-1740.
Crossref
Crossref
Melih ŞİMŞEK, Ulaş IŞIK & Orkun GÜRBÜZ. (2022) Malign mezotelyomada kemoterapi uygulamalarıChemotherapy applications in malign mesothelioma. Ege Tıp Dergisi 61:1, pages 15-21.
Crossref
Crossref
Taylan Özgür Sezer, Almir Miftari, Özgür Fırat & Sinan Ersin. (2021) Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malign Peritoneal Mesothelioma: Clinical Aspects and Therapeutic Perspectives. Indian Journal of Surgery 84:1, pages 21-27.
Crossref
Crossref
Glaucia N. M. Hajj1,2Carolina H. Cavarson1,2Clóvis Antônio Lopes Pinto3Gabriela Venturi1,4João R. Navarro4Vladmir C. Cordeiro de Lima2,5. (2021) Malignant pleural mesothelioma: an update. Jornal Brasileiro de Pneumologia, pages e20210129.
Crossref
Crossref
R. Taylor Ripley, Nihanth Palivela, Shawn S. Groth, Eugene A. Choi, Lorraine D. Cornwell, Philip W. Carrott, George Van Buren, Taylor G. Splawn, David J. Sugarbaker & Bryan M. Burt. (2021) Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma With Routine Positron Emission Tomography Imaging. The Annals of Thoracic Surgery 112:5, pages 1568-1574.
Crossref
Crossref
Srinivas R. Mummadi, James K. Stoller, Rocio Lopez, Karthik Kailasam, Colin T. Gillespie & Peter Y. Hahn. (2021) Epidemiology of Adult Pleural Disease in the United States. Chest 160:4, pages 1534-1551.
Crossref
Crossref
Soon-Chan Kwon, Sung-Soo Lee, Min-Sung Kang, Da-An Huh & Yong-Jin Lee. (2021) The Epidemiologic Characteristics of Malignant Mesothelioma Cases in Korea: Findings of the Asbestos Injury Relief System from 2011–2015. International Journal of Environmental Research and Public Health 18:19, pages 10007.
Crossref
Crossref
Fabio Nicolini & Massimiliano Mazza. 2021. Rare Diseases - Diagnostic and Therapeutic Odyssey. Rare Diseases - Diagnostic and Therapeutic Odyssey.
Xaver Baur, Arthur L. Frank, Colin L. Soskolne, L. Christine Oliver & Corrado Magnani. (2021) Malignant mesothelioma: Ongoing controversies about its etiology in females. American Journal of Industrial Medicine 64:7, pages 543-550.
Crossref
Crossref
Anne-Laure Désage, Georgia Karpathiou, Michel Peoc’h & Marios E. Froudarakis. (2021) The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review. Cancers 13:13, pages 3205.
Crossref
Crossref
Kyeongmin Kwak, Sung-il Cho & Domyung Paek. (2021) Future Incidence of Malignant Mesothelioma in South Korea: Updated Projection to 2038. International Journal of Environmental Research and Public Health 18:12, pages 6614.
Crossref
Crossref
David B Chapel, Adrian M Dubuc, Jason L Hornick & Lynette M Sholl. (2021)
Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with
MTAP
and
CDKN2A
copy number in malignant pleural mesothelioma
. Histopathology 78:7, pages 1032-1042.
Crossref
Crossref
Suzanne L. Walker, Janice D. Crist, Kimberly Shea, Sara Holland & Pamela Z. Cacchione. (2021) The Lived Experience of Persons With Malignant Pleural Mesothelioma in the United States. Cancer Nursing 44:2, pages E90-E98.
Crossref
Crossref
Lamyae Nouiakh, Zineb Benbrahim, Karima Oualla, Abdelkrim Haita, Imane Ouafki, Soumia Berrad, Hayat Erraichi, Lamiae Amaadour, Samia Arif, Hind El Fatemi & Nawfel Mellas. (2021) Malignant pleural mesothelioma: Experience of the Medical Oncology Department of Hassan II Hospital in Fez, Morocco. Journal of Lung, Pulmonary & Respiratory Research 8:1, pages 6-11.
Crossref
Crossref
S. Kusamura, V. Kepenekian, L. Villeneuve, R.J. Lurvink, K. Govaerts, I.H.J.T. De Hingh, B.J. Moran, K. Van der Speeten, M. Deraco, O. Glehen, Pedro Barrios-Sanchez, Joel M. Baumgartner, Almog Ben-Yaacov, Rosella Bertulli, Peter Cashin, Tom Cecil, Sanjeev Dayal, Michele De Simone, Jason M. Foster, Diane Goere, Kuno Lehmann, Yan Li, Brian W. Loggie, Faheez Mohamed, David L. Morris, Aviram Nissan, Pompiliu Piso, Marc Pocard, Beate Rau, Marc A. Reymond, Lucas Sideris, John D. Spiliotis, Paul H. Sugarbaker, Victor J. Verwaal, Malcom S. Wilson, Yutaka Yonemura & Yang Yu. (2021) Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. European Journal of Surgical Oncology 47:1, pages 36-59.
Crossref
Crossref
Mackenzie C. Morris, Jordan M. Cloyd, John Hays & Sameer H. Patel. (2020) The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies. Journal of Gastrointestinal Surgery 25:1, pages 303-318.
Crossref
Crossref
Michele Carbone, Michael Minaai, Sandra Pastorino & Haining Yang. 2021. Malignant Pleural Mesothelioma. Malignant Pleural Mesothelioma
151
165
.
Daniel J. LauerIIIIII, Kenneth A. Mundt, William J. Thompson & Elizabeth A. Best. (2020) Letter to the Editor: Largely Unchanged Annual Incidence and Overall Survival of Pleural Mesothelioma in the USA. World Journal of Surgery 44:12, pages 4279-4280.
Crossref
Crossref
Benjamin Wadowski, David T. Severson, Raphael Bueno & Assunta De Rienzo. 2020. Mesothelioma. Mesothelioma.
Derek B. Oien, Jeremy Chien, Julian Molina & Viji Shridhar. 2020. Mesothelioma. Mesothelioma.
Luis E. De León, Carlos E. Bravo-Iñiguez, Sam Fox, Jeffrey Tarascio, Samuel Freyaldenhoven, Moshe Lapidot, Michael T. Jaklitsch & Raphael Bueno. (2020) Routine surveillance for diagnosis of venous thromboembolism after pleurectomy for malignant pleural mesothelioma. The Journal of Thoracic and Cardiovascular Surgery 160:4, pages 1064-1073.
Crossref
Crossref
Eunice Sirri, Joachim Kieschke, Claudia Vohmann, Alexander Katalinic, Alice Nennecke, Meike Ressing, Andrea Eberle, Bernd Holleczek, Lina Jansen & Hermann Brenner. (2020) Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population‐based study. International Journal of Cancer 147:6, pages 1548-1558.
Crossref
Crossref
Isabelle Opitz, Arnaud Scherpereel, Thierry Berghmans, Ioannis Psallidas, Markus Glatzer, David Rigau, Philippe Astoul, Servet Bölükbas, Jeanette Boyd, Johan Coolen, Charlotte De Bondt, Dirk De Ruysscher, Valerie Durieux, Corinne Faivre-Finn, Dean A Fennell, Francoise Galateau-Salle, Laurent Greillier, Mir Ali Hoda, Walter Klepetko, Aude Lacourt, Phil McElnay, Nick A Maskell, Luciano Mutti, Jean-Claude Pairon, Paul Van Schil, Jan P van Meerbeeck, David Waller, Walter Weder, Paul Martin Putora & Giuseppe Cardillo. (2020) ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. European Journal of Cardio-Thoracic Surgery 58:1, pages 1-24.
Crossref
Crossref
Avishek Choudhury. (2020) Predicting cancer using supervised machine learning: Mesothelioma. Technology and Health Care, pages 1-14.
Crossref
Crossref
. (2020) The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma. Annals of Surgical Oncology 27:6, pages 1774-1779.
Crossref
Crossref
Arnaud Scherpereel, Isabelle Opitz, Thierry Berghmans, Ioannis Psallidas, Markus Glatzer, David Rigau, Philippe Astoul, Servet Bölükbas, Jeanette Boyd, Johan Coolen, Charlotte De Bondt, Dirk De Ruysscher, Valerie Durieux, Corinne Faivre-Finn, Dean Fennell, Francoise Galateau-Salle, Laurent Greillier, Mir Ali Hoda, Walter Klepetko, Aude Lacourt, Phil McElnay, Nick A. Maskell, Luciano Mutti, Jean-Claude Pairon, Paul Van Schil, Jan P. van Meerbeeck, David Waller, Walter Weder, Giuseppe Cardillo & Paul Martin Putora. (2020) ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. European Respiratory Journal 55:6, pages 1900953.
Crossref
Crossref
Eric Pletcher, Elizabeth Gleeson & Daniel Labow. (2020) Peritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy. Surgical Clinics of North America 100:3, pages 589-613.
Crossref
Crossref
Darryl Schuitevoerder, Francisco J. Izquierdo, Alejandro Plana, Garrett M. Nash, Leopoldo J. Fernandez, Michael D. Kluger, Lloyd A. Mack, Joshua M. V. Mammen, Colette R. Pameijer, Patricio M. Polanco, Lucas Sideris, Joseph Skitzki, Daniel E. Abbott, Sherif Abdel‐Misih, Steven A. Ahrendt, Mazin Al‐Kasspooles, Farin Amersi, Amanda K. Arrington, Brian Badgwell, Robert M. Barone, Joel M. Baumgartner, Richard N. Berri, Lana Bijelic, Dan G. BlazerIIIIII, Wilbur B. Bowne, Charles Komen Brown, Daniel V. Catenacci, Carlos H. F. Chan, Christopher S. Chandler, David B. Chapel, Clifford S. Cho, M. Haroon A. Choudry, Callisia N. Clarke, James C. CusackJrJr, Abraham H. Dachman, Jeremiah L. Deneve, Sean P. Dineen, Oliver S. Eng, James Fleshman, T. Clark Gamblin, Alexandra Gangi, Georgios V. Georgakis, Erin W. Gilbert, Martin D. Goodman, Anand Govindarajan, Travis E. Grotz, Vadim Gushchin, Nader Hanna, Carla Harmath, Andrea Hayes‐Jordan, Aliya N. Husain, Kamran Idrees, Chukwuemeka Ihemelandu, Haejin In, David Jiang, Fabian M. Johnston, John M. KaneIIIIII, Giorgos Karakousis, Kaitlyn J. Kelly, Timothy J. Kennedy, Xavier M. Keutgen, Hedy Lee Kindler, Byrne Lee, Ugwuji N. Maduekwe, Grace Z. Mak, Marcovalerio Melis, Nelya Melnitchouk, Melvy Sarah Mathew, Ryan P. Merkow, Harveshp Mogal, Mecker G. Möller, Aytekin Oto, Sam G. Pappas, Blase N. Polite, Sanjay S. Reddy, Richard Royal, George Salti, Armando Sardi, Maheswari Senthil, Namrata Setia, Scott K. Sherman, Jula Veerapong, Konstantinos I. Votanopoulos, Michael G. White, Joshua H. Winer, Shu‐Yuan Xiao, Rhonda K. Yantiss, Nita Ahuja, Andrew M. Lowy, H. Richard AlexanderJrJr, Jesus Esquivel, Jason M. Foster, Daniel M. Labow, Laura A. Lambert, Edward A. Levine, Charles Staley, Paul H. Sugarbaker, David L. Bartlett & Kiran Turaga. (2020) The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. Cancer 126:11, pages 2547-2552.
Crossref
Crossref
Theresa S. Emory, John C. Maddox & Richard L. Kradin. (2020) Malignant mesothelioma following repeated exposures to cosmetic talc: A case series of 75 patients. American Journal of Industrial Medicine 63:6, pages 484-489.
Crossref
Crossref
Fabio Nicolini, Martine Bocchini, Davide Angeli, Giuseppe Bronte, Angelo Delmonte, Lucio Crinò & Massimiliano Mazza. (2020) Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting. Cancers 12:4, pages 915.
Crossref
Crossref
Katsuyuki Hotta & Nobukazu Fujimoto. (2020) Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma. Journal for ImmunoTherapy of Cancer 8:1, pages e000461.
Crossref
Crossref
Fabio Nicolini, Martine Bocchini, Giuseppe Bronte, Angelo Delmonte, Massimo Guidoboni, Lucio Crinò & Massimiliano Mazza. (2020) Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future. Frontiers in Oncology 9.
Crossref
Crossref
Zubair Bayat, Emily L. Taylor, Danielle A. Bischof, J. Andrea McCart & Anand Govindarajan. (2019) Impairments in Bowel Function, Social Function and Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology 27:1, pages 124-131.
Crossref
Crossref
Jacqueline Moline, Kristin Bevilacqua, Maya Alexandri & Ronald E. Gordon. (2020) Mesothelioma Associated With the Use of Cosmetic Talc. Journal of Occupational & Environmental Medicine 62:1, pages 11-17.
Crossref
Crossref
S. Jane HenleyLucy A. PeipinsSun Hee RimTheodore C. LarsonJacqueline W. Miller. (2020) Geographic Co-Occurrence of Mesothelioma and Ovarian Cancer Incidence. Journal of Women's Health 29:1, pages 111-118.
Crossref
Crossref
Paul Markowitz, Malini Patel, Roman Groisberg, Joseph Aisner, Salma K. Jabbour, Subhajyoti De, Shridar Ganesan & Jyoti Malhotra. (2020) Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes. Cancer Treatment and Research Communications 25, pages 100232.
Crossref
Crossref
Richard L. Attanoos. 2020. Occupational Cancers. Occupational Cancers
363
378
.
Laura M. Enomoto, Perry Shen, Konstantinos I. Votanopoulos & Edward A. Levine. 2020. Cancer Regional Therapy. Cancer Regional Therapy
141
153
.
Darragh Halpenny, Micheal Raj, Andreas Rimner, Junting Zheng, Marinela Capanu & Michelle S. Ginsberg. (2019) Computed tomography features of local pleural recurrence in patients with malignant pleural mesothelioma treated with intensity-modulated pleural radiation therapy. European Radiology 29:7, pages 3696-3704.
Crossref
Crossref
Hiroki Sato, Junichi Soh, Keisuke Aoe, Nobukazu Fujimoto, Shin Tanaka, Kei Namba, Hidejiro Torigoe, Kazuhiko Shien, Hiromasa Yamamoto, Shuta Tomida, Hiroyuki Tao, Kazunori Okabe, Takumi Kishimoto & Shinichi Toyooka. (2019) Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma. International Journal of Oncology.
Crossref
Crossref
Hongbing Sun. (2019) North-south gradient of mesothelioma and asbestos consumption-production in the United States-Progresses since the 1st asbestos partial ban in 1973. American Journal of Industrial Medicine 62:4, pages 337-346.
Crossref
Crossref
Arnold R. Brody. (2019) How Inhaled Asbestos Causes Scarring and Cancer. Current Respiratory Medicine Reviews 14:4, pages 204-217.
Crossref
Crossref
Ting Wang, Meng Cui & Asmitananda Thakur. (2019) Localized intrapulmonary mesothelioma presenting with a pulmonary mass. Indian Journal of Pathology and Microbiology 62:4, pages 636.
Crossref
Crossref
Carrie D. Tomasallo, Krista Y. Christensen, Michelle Raymond, Paul D. Creswell, Henry A. Anderson & Jon G. Meiman. (2018) An Occupational Legacy. Journal of Occupational & Environmental Medicine 60:12, pages 1143-1149.
Crossref
Crossref
Paolo Boffetta, Kenneth A. Mundt & William J. Thompson. (2018) The epidemiologic evidence for elongate mineral particle (EMP)-related human cancer risk. Toxicology and Applied Pharmacology 361, pages 100-106.
Crossref
Crossref
Song Hui, Zheng Guo-Qi, Guo Xiao-Zhong, Liu Chun-Rong, Liang Yu-Fei & Yang Dong-Liang. (2018) IMP3 as a prognostic biomarker in patients with malignant peritoneal mesothelioma. Human Pathology 81, pages 138-147.
Crossref
Crossref
Sherif Abbas, Nihal Simsek Ozek, Salih Emri, Deniz Koksal, Mete Severcan & Feride Severcan. (2018) Diagnosis of malignant pleural mesothelioma from pleural fluid by Fourier transform-infrared spectroscopy coupled with chemometrics. Journal of Biomedical Optics 23:10, pages 1.
Crossref
Crossref
Eyjolfur Gudmundsson, Christopher M. Straus & Samuel G. Armato. (2018) Deep convolutional neural networks for the automated segmentation of malignant pleural mesothelioma on computed tomography scans. Journal of Medical Imaging 5:03, pages 1.
Crossref
Crossref
Vivek Verma, Richard L. Sleightholm, Chad G. Rusthoven, Matthew Koshy, David J. Sher, Surbhi Grover & Charles B. SimoneIIII. (2018) Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival. Annals of Surgical Oncology 25:7, pages 2018-2026.
Crossref
Crossref
Richard L. Attanoos, Andrew Churg, Francoise Galateau-Salle, Allen R. Gibbs & Victor L. Roggli. (2018) Malignant Mesothelioma and Its Non-Asbestos Causes. Archives of Pathology & Laboratory Medicine 142:6, pages 753-760.
Crossref
Crossref
Meghan E. Glynn, Kara A. Keeton, Shannon H. Gaffney & Jennifer Sahmel. (2017) Ambient Asbestos Fiber Concentrations and Long‐Term Trends in Pleural Mesothelioma Incidence between Urban and Rural Areas in the United States (1973–2012). Risk Analysis 38:3, pages 454-471.
Crossref
Crossref
Arnaud Scherpereel, Frederic Wallyn, Steven M Albelda & Camille Munck. (2018) Novel therapies for malignant pleural mesothelioma. The Lancet Oncology 19:3, pages e161-e172.
Crossref
Crossref
Paolo BoffettaMatteo MalvezziEnrico PiraEva NegriCarlo La Vecchia. (2018) International Analysis of Age-Specific Mortality Rates From Mesothelioma on the Basis of the International Classification of Diseases, 10th Revision. Journal of Global Oncology:4, pages 1-15.
Crossref
Crossref
Agata Szymiczek, Sandra Pastorino, David Larson, Mika Tanji, Laura Pellegrini, Jiaming Xue, Shuangjing Li, Carlotta Giorgi, Paolo Pinton, Yasutaka Takinishi, Harvey I. Pass, Hideki Furuya, Giovanni Gaudino, Andrea Napolitano, Michele Carbone & Haining Yang. (2017) FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model. Journal of Translational Medicine 15:1.
Crossref
Crossref
A Szymiczek, M Carbone, S Pastorino, A Napolitano, M Tanji, M Minaai, I Pagano, J M Mason, H I Pass, M R Bray, T W Mak & H Yang. (2017) Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma. Oncogene 36:46, pages 6501-6507.
Crossref
Crossref
Daniel F. Pease & Robert A. Kratzke. (2017) Oncolytic Viral Therapy for Mesothelioma. Frontiers in Oncology 7.
Crossref
Crossref
Laura Pellegrini, Jiaming Xue, David Larson, Sandra Pastorino, Sandro Jube, Kelly H. Forest, Zeyana Salim Saad-Jube, Andrea Napolitano, Ian Pagano, Vishal S. Negi, Marco E. Bianchi, Paul Morris, Harvey I. Pass, Giovanni Gaudino, Michele Carbone & Haining Yang. (2017) HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma. Oncotarget 8:14, pages 22649-22661.
Crossref
Crossref
Zhenying Guo, Michele Carbone, Xing Zhang, Dan Su, Wenyong Sun, Jianlin Lou, Zhibin Gao, Dichu Shao, Junqiang Chen, Gu Zhang, Jinlin Hu, Kaiyan Chen, Fang Wang, Harvey I. Pass, Herbert Yu, Andrea Napolitano, Haining Yang & Weimin Mao. (2017) Improving the Accuracy of Mesothelioma Diagnosis in China. Journal of Thoracic Oncology 12:4, pages 714-723.
Crossref
Crossref
Noushin Nabavi, Kevin L. Bennewith, Andrew Churg, Yuzhuo Wang, Colin C. Collins & Luciano Mutti. (2017) Switching off malignant mesothelioma: exploiting the hypoxic microenvironment. Genes & Cancer 7:11-12, pages 340-354.
Crossref
Crossref
Assunta De Rienzo, Robert W. Cook, Jeff Wilkinson, Corinne E. Gustafson, Waqas Amin, Clare E. Johnson, Kristen M. Oelschlager, Derek J. Maetzold, John F. Stone, Michael D. Feldman, Michael J. Becich, Beow Y. Yeap, William G. Richards & Raphael Bueno. (2017) Validation of a Gene Expression Test for Mesothelioma Prognosis in Formalin-Fixed Paraffin-Embedded Tissues. The Journal of Molecular Diagnostics 19:1, pages 65-71.
Crossref
Crossref
Assunta De Rienzo, William G. Richards & Raphael Bueno. 2017. Asbestos and Mesothelioma. Asbestos and Mesothelioma
197
209
.
Suresh H. Moolgavkar, Ellen T. Chang, Gabor Mezei & Fionna S. Mowat. 2017. Asbestos and Mesothelioma. Asbestos and Mesothelioma
43
72
.
Joseph R. Testa. 2017. Asbestos and Mesothelioma. Asbestos and Mesothelioma
1
9
.
Hedy Lee Kindler. (2016) The Challenge of Defining Treatment Standards for a Rare Disease: Malignant Peritoneal Mesothelioma. Journal of Oncology Practice 12:10, pages 936-937.
Crossref
Crossref
Michele Carbone, David Shimizu, Andrea Napolitano, Mika Tanji, Harvey I. Pass, Haining Yang & Sandra Pastorino. (2016) Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma. Oncotarget 7:37, pages 59314-59321.
Crossref
Crossref
Andrea Napolitano & Michele Carbone. (2016) Malignant Mesothelioma: Time to Translate?. Trends in Cancer 2:9, pages 467-474.
Crossref
Crossref
Michele Carbone, Shreya Kanodia, Ann Chao, Aubrey Miller, Anil Wali, David Weissman, Alex Adjei, Francine Baumann, Paolo Boffetta, Brenda Buck, Marc de Perrot, A. Umran Dogan, Steve Gavett, Alessandro Gualtieri, Raffit Hassan, Mary Hesdorffer, Fred R. Hirsch, David Larson, Weimin Mao, Scott Masten, Harvey I. Pass, Julian Peto, Enrico Pira, Ian Steele, Anne Tsao, Gavitt Alida Woodard, Haining Yang & Shakun Malik. (2016) Consensus Report of the 2015 Weinman International Conference on Mesothelioma. Journal of Thoracic Oncology 11:8, pages 1246-1262.
Crossref
Crossref
Andrea Napolitano, Daniel J. Antoine, Laura Pellegrini, Francine Baumann, Ian Pagano, Sandra Pastorino, Chandra M. Goparaju, Kirill Prokrym, Claudia Canino, Harvey I. Pass, Michele Carbone & Haining Yang. (2016) HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients. Clinical Cancer Research 22:12, pages 3087-3096.
Crossref
Crossref
Yuwaraj Kadariya, Craig W. Menges, Jacqueline Talarchek, Kathy Q. Cai, Andres J. Klein-Szanto, Ralph A. Pietrofesa, Melpo Christofidou-Solomidou, Mitchell Cheung, Brooke T. Mossman, Arti Shukla & Joseph R. Testa. (2016) Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma. Cancer Prevention Research 9:5, pages 406-414.
Crossref
Crossref
A Napolitano, L Pellegrini, A Dey, D Larson, M Tanji, E G Flores, B Kendrick, D Lapid, A Powers, S Kanodia, S Pastorino, H I Pass, V Dixit, H Yang & M Carbone. (2015) Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene 35:15, pages 1996-2002.
Crossref
Crossref
Mahadev Rao, Scott M. Atay, Vivek Shukla, Young Hong, Trevor Upham, R. Taylor Ripley, Julie A. Hong, Mary Zhang, Emily Reardon, Patricia Fetsch, Markku Miettinen, Xinmin Li, Cody J. Peer, Tristan Sissung, William D. Figg, Assunta De Rienzo, Raphael Bueno & David S. Schrump. (2016) Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells. Clinical Cancer Research 22:5, pages 1197-1210.
Crossref
Crossref
Assunta De Rienzo, Michael A. Archer, Beow Y. Yeap, Nhien Dao, Daniele Sciaranghella, Antonios C. Sideris, Yifan Zheng, Alexander G. Holman, Yaoyu E. Wang, Paola S. Dal Cin, Jonathan A. Fletcher, Renee Rubio, Larry Croft, John Quackenbush, Peter E. Sugarbaker, Kiara J. Munir, Jesse R. Battilana, Corinne E. Gustafson, Lucian R. Chirieac, Soo Meng Ching, James Wong, Liang Chung Tay, Stephen Rudd, Robert Hercus, David J. Sugarbaker, William G. Richards & Raphael Bueno. (2016) Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma. Cancer Research 76:2, pages 319-328.
Crossref
Crossref
Jill A. Ohar, Mitchell Cheung, Jacqueline Talarchek, Suzanne E. Howard, Timothy D. Howard, Mary Hesdorffer, Hongzhuang Peng, Frank J. Rauscher & Joseph R. Testa. (2016) Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer. Cancer Research 76:2, pages 206-215.
Crossref
Crossref
Mitchell Cheung, Yuwaraj Kadariya, Jacqueline Talarchek, Jianming Pei, Jill A. Ohar, Omar R. Kayaleh & Joseph R. Testa. (2015) Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene–environment interaction. Cancer Letters 369:2, pages 261-265.
Crossref
Crossref
Steve C. Gold. (2015) Drywall Mud and Muddy Doctrine: How Not to Decide a Multiple-Exposure Mesothelioma Case. Indiana Law Review 49:1, pages 117.
Crossref
Crossref
Anish Thomas, Yuanbin Chen, Tinghui Yu, Ammara Gill & Vinay Prasad. (2015) Distinctive clinical characteristics of malignant mesothelioma in young patients. Oncotarget 6:18, pages 16766-16773.
Crossref
Crossref
Francine Baumann, Brenda J. Buck, Rodney V. Metcalf, Brett T. McLaurin, Douglas J. Merkler & Michele Carbone. (2015) The Presence of Asbestos in the Natural Environment is Likely Related to Mesothelioma in Young Individuals and Women from Southern Nevada. Journal of Thoracic Oncology 10:5, pages 731-737.
Crossref
Crossref
Akif Burak Tosun, Oleksandr Yergiyev, Soheil Kolouri, Jan F. Silverman & Gustavo K. Rohde. (2015) Detection of malignant mesothelioma using nuclear structure of mesothelial cells in effusion cytology specimens. Cytometry Part A 87:4, pages 326-333.
Crossref
Crossref
M Adrián Ortega-Guerrero, Gerardo Carrasco-Núñez, Héctor Barragán-Campos & Martín R Ortega. (2015) High incidence of lung cancer and malignant mesothelioma linked to erionite fibre exposure in a rural community in Central Mexico: Table 1. Occupational and Environmental Medicine 72:3, pages 216-218.
Crossref
Crossref
Francine Baumann, Erin Flores, Andrea Napolitano, Shreya Kanodia, Emanuela Taioli, Harvey Pass, Haining Yang & Michele Carbone. (2015) Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis 36:1, pages 76-81.
Crossref
Crossref
Dana Hashim & Paolo Boffetta. (2014) Occupational and Environmental Exposures and Cancers in Developing Countries. Annals of Global Health 80:5, pages 393.
Crossref
Crossref
Sabahattin Comertpay, Sandra Pastorino, Mika Tanji, Rosanna Mezzapelle, Oriana Strianese, Andrea Napolitano, Francine Baumann, Tracey Weigel, Joseph Friedberg, Paul Sugarbaker, Thomas Krausz, Ena Wang, Amy Powers, Giovanni Gaudino, Shreya Kanodia, Harvey I Pass, Barbara L Parsons, Haining Yang & Michele Carbone. (2014) Evaluation of clonal origin of malignant mesothelioma. Journal of Translational Medicine 12:1.
Crossref
Crossref
Paolo Girardi, Vittoria Bressan & Enzo Merler. (2014) Past trends and future prediction of mesothelioma incidence in an industrialized area of Italy, the Veneto Region. Cancer Epidemiology 38:5, pages 496-503.
Crossref
Crossref
A Reid, N H de Klerk, C Magnani, D Ferrante, G Berry, A W Musk & E Merler. (2014) Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis. Thorax 69:9, pages 843-850.
Crossref
Crossref
Jinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, Jianming Pei, Jacqueline Talarchek, Eleonora Sementino, Yinfei Tan, Craig W. Menges, Kathy Q. Cai, Samuel Litwin, Hongzhuang Peng, Jayashree Karar, Frank J. Rauscher & Joseph R. Testa. (2014)
Germline Mutation of
Bap1
Accelerates Development of Asbestos-Induced Malignant Mesothelioma
. Cancer Research 74:16, pages 4388-4397.
Crossref
Crossref
Aaron Scott Mansfield, Anja C. Roden, Tobias Peikert, Yuri M. Sheinin, Susan M. Harrington, Christopher J. Krco, Haidong Dong & Eugene D. Kwon. (2014) B7-H1 Expression in Malignant Pleural Mesothelioma is Associated with Sarcomatoid Histology and Poor Prognosis. Journal of Thoracic Oncology 9:7, pages 1036-1040.
Crossref
Crossref
Aaron H. Rose, Pietro Bertino, FuKun W. Hoffmann, Giovanni Gaudino, Michele Carbone & Peter R. Hoffmann. (2014) Increasing Dietary Selenium Elevates Reducing Capacity and ERK Activation Associated with Accelerated Progression of Select Mesothelioma Tumors. The American Journal of Pathology 184:4, pages 1041-1049.
Crossref
Crossref
Nancy C. Wojcik, A. Robert Schnatter & Wendy W. Huebner. (2014) Mesothelioma in Occupational Cohort Studies. Journal of Occupational & Environmental Medicine 56:1, pages 47-51.
Crossref
Crossref
Fang Qi, Gordon Okimoto, Sandro Jube, Andrea Napolitano, Harvey I. Pass, Rozalia Laczko, Richard M. DeMay, Ghazal Khan, Maarit Tiirikainen, Caterina Rinaudo, Alessandro Croce, Haining Yang, Giovanni Gaudino & Michele Carbone. (2013) Continuous Exposure to Chrysotile Asbestos Can Cause Transformation of Human Mesothelial Cells via HMGB1 and TNF-α Signaling. The American Journal of Pathology 183:5, pages 1654-1666.
Crossref
Crossref